Plerixafor
Active substance: plerixafor
INJECTION, SOLUTION · PLERIXAFOR 24 mg/1.2mL
United StatesActive
Marketing holder: Gland Pharma Limited
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- PLERIXAFOR · 24 mg/1.2mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 2 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-29a9-7062-bef6-211017b58cca,01a1208c-7723-73ca-8c89-719c9f079c06,01a1208c-989d-7d70-88ab-3f15084fc3d8,01a1208d-03d8-7095-af8d-cf4fa96ad05d,01a1208d-05c2-7eb3-aa18-3e323719248c;count=13 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 68083-155
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 68083-155 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 68083-155 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 68083-155 · Verified 2026-10-09 · open in source